KarlRHansenMD
Obstetrics & Gynecology • Oklahoma City, OKReproductive Endocrinology & Infertility
Assistant Professor, Obstetrics & Gynecology, University of Oklahoma
Are you Dr. Hansen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 N Lincoln Blvd
Ste 300
Oklahoma City, OK 73104Phone+1 405-271-1616Fax+1 405-271-9222
Summary
- Dr. Karl Hansen, MD is an obstetrician/gynecologist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma. He is affiliated with OU Health and is an Assistant Professor at University of Oklahoma.
Education & Training
University of Oklahoma College of MedicineClass of 1997
Certifications & Licensure
OK State Medical License 1998 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Reproductive Endocrinology/Infertility
Publications & Presentations
PubMed
- Assessment of clinical pregnancies in up to eight ovarian stimulation with intrauterine insemination treatment cycles in those unable to proceed with in vitro fertiliz...M Blake Evans, Pardis Hosseinzadeh, Kerry Flannagan, Samad Jahandideh, Emilie Burruss
Fertility and Sterility. 2024-07-01 - High antimüllerian hormone level in oocyte donors: Is it a problem?Ashley Ulker, Karl R Hansen
Fertility and Sterility. 2024-02-01 - Follicular phase length is not related to live birth outcome in women with unexplained infertility undergoing ovarian stimulation with intrauterine insemination cycles...Pardis Hosseinzadeh, Jennifer D Peck, Heather R Burks, Irene Souter, Angela Xing
F&S Reports. 2023-12-01
Press Mentions
OU Health Sciences Leads Clinical Trial of Device Designed to Induce Ovulation in Women with PCOSDecember 17th, 2024- Induction of Ovulation in Women with PCOS: Device Moves to Clinical Trial Stage - VideoDecember 6th, 2024
